• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Progenics Pharmaceuticals, Inc. (PGNX)

    -NasdaqGS
    6.97 Down 0.12(1.69%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:7.09
    Open:7.12
    Bid:6.75 x 100
    Ask:7.30 x 300
    1y Target Est:9.50
    Beta:2.75
    Earnings Date:Aug 6 - Aug 10 (Est.)
    Day's Range:6.92 - 7.36
    52wk Range:4.02 - 9.27
    Volume:1,260,998
    Avg Vol (3m):1,169,530
    Market Cap:485.43M
    P/E (ttm):154.89
    EPS (ttm):0.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PGNX

    Comparison

    Symbol% ChgMkt Cap
    PGNXDown 1.69%485.43M
    DNDN 0.00%0.00
    NKTRDown 1.90%1.56B

    Key Statistics

    Forward P/E (1 yr):697.00
    P/S (ttm):11.53
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.51
    Quarterly EPS Est (Jun-15) :-0.14
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.54

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Progenics Pharmaceuticals, Inc. develops medicines for oncology in the United States and internationally. The company’s primary clinical-stage product candidates include prostate specific membrane antigen (PSMA) antibody-drug conjugate, which... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback